FDA approves lirafugratinib for previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma
Story updates
07:42:17 PM UTC
SquawkNews
FDA Approves Lirafugratinib For Previously Treated Advanced Cholangiocarcinoma